AARP: Biologics Bill Will Lower Prices Of Most Expensive Drugs, USA

Main Category: Pharmacy / Pharmacist
Also Included In: Public Health
Article Date: 16 Mar 2009 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:2 stars

2 (1 votes)

Healthcare Prof:not yet rated


AARP applauded the introduction of bipartisan legislation to lower the cost of prescription drugs. The Access to Life-Saving Medicine Act, introduced by Chairman Henry Waxman (D-CA), Rep. Frank Pallone (D-NJ), Rep. Nathan Deal (R-GA) and Rep. Jo Ann Emerson (R-MO), will create a needed pathway for the approval of safe generic versions of costly biologic drugs. A statement from AARP Executive Vice President Nancy LeaMond follows:

"Biologic drugs are treating some of the most devastating diseases Americans face, like cancer, anemia and multiple sclerosis. But for too many people, these life-saving medicines are simply out of reach because of their overwhelming price tags.

"As we learned when Rep. Waxman and Sen. Hatch championed generic drug legislation in the 1980s, generic competition has incredible power to bring down prices without hindering the development of new, life-saving medicines. Now we have the opportunity to introduce similar cost savings to these new-and often expensive-breakthrough drugs.

"AARP applauds the bipartisan sponsors of the Access to Life-Saving Medicine Act, which will help bring safe, less expensive generic versions of biologic drugs to market. These drugs, which can cost as much as $300,000 per year, do not face competition from lower- cost generic versions. The bill introduced by Reps. Waxman, Pallone, Deal and Emerson will make biologics more accessible to the millions of Americans who cannot afford brand name versions.

"The country will not reach the goal of quality, affordable health care for every American without controlling the skyrocketing cost of drugs. We look forward to working with Chairman Waxman and his colleagues to pass this legislation this year as a part of comprehensive health reform."

AARP is a nonprofit, nonpartisan membership organization that helps people 50+ have independence, choice and control in ways that are beneficial and affordable to them and society as a whole. AARP does not endorse candidates for public office or make contributions to either political campaigns or candidates. We produce AARP The Magazine, the definitive voice for 50+ Americans and the world's largest-circulation magazine with over 34.5 million readers; AARP Bulletin, the go-to news source for AARP's 40 million members and Americans 50+; AARP Segunda Juventud, the only bilingual U.S. publication dedicated exclusively to the 50+ Hispanic community; and our website, http://www.AARP.org. AARP Foundation is an affiliated charity that provides security, protection, and empowerment to older persons in need with support from thousands of volunteers, donors, and sponsors. We have staffed offices in all 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands.

http://www.AARP.org

Article adapted by Medical News Today from original press release.
Visit our pharmacy / pharmacist section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
AARP. "AARP: Biologics Bill Will Lower Prices Of Most Expensive Drugs, USA." Medical News Today. MediLexicon, Intl., 16 Mar. 2009. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/142391.php>

APA
AARP. (2009, March 16). "AARP: Biologics Bill Will Lower Prices Of Most Expensive Drugs, USA." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/142391.php.

Please note: If no author information is provided, the source is cited instead.


Pharmacy / Pharmacist

Most Popular Articles



Follow Our Pharmacy News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharmacy / Pharmacist Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »